{
    "eid": "2-s2.0-84954349032",
    "title": "Galectin-3 in cardiac muscle and circulation of dogs with degenerative mitral valve disease",
    "cover-date": "2016-03-01",
    "subject-areas": [
        {
            "$": "Physiology",
            "@code": "1314"
        },
        {
            "$": "General Veterinary",
            "@code": "3400"
        }
    ],
    "keywords": [
        "Biomarker",
        "Canine",
        "Cardiac fibrosis",
        "Congestive heart failure",
        "Myxomatous mitral valve disease"
    ],
    "authors": [
        "S. Sakarin"
    ],
    "citedby-count": 9,
    "ref-count": 40,
    "ref-list": [
        "Myxomatous degenerative mitral valve disease: An update",
        "Cardiac fibrosis as a cause of diastolic dysfunction",
        "Cardiac remodeling-concepts and clinical implications: A consensus paper from an International Forum on Cardiac Remodeling",
        "Arteriosclerotic changes in the myocardium, lung, and kidney in dogs with chronic congestive heart failure and myxomatous mitral valve disease",
        "Associations between cardiac pathology and clinical, echocardiographic and electrocardiographic findings in dogs with chronic congestive heart failure",
        "Induction of cardiac fibrosis by aldosterone",
        "Biomarkers in cardiovascular disease: Beyond natriuretic peptides",
        "Associations among serum N-terminal procollagen type III concentration, urinaryaldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease",
        "Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen tyoe III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs",
        "Galectin-3: A novel mediator of heart failure development and progression",
        "Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community",
        "Prognostic value of galectin-3, a novel marker of fibrosis,in patients with chronic heart failure: Data from the DEAL-HF study",
        "Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction",
        "Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction",
        "Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: Insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial",
        "Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation",
        "Immunohistochemical expression of galectin-3 in canine mammary tumours",
        "Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia",
        "Collagen and glycosaminoglycan profiles in the canine cervix during different stages of the estrous cycle and in open- and closed-cervix pyometra",
        "Veterinary Internal Medicine",
        "Manual of Small Animal Emergency and Critical Care Medicine",
        "ECHOCARDIOGRAPHIC INDICES IN THE NORMAL DOG",
        "Echocardiographic assessment of canine degenerative mitral valve disease",
        "Guidelines for the diagnosis and treatment of canine chronic valvular heart disease",
        "Manual of Canine galectin-3 (GAL3) ELISA Kit",
        "Pharmacologic management of myxomatous mitral valve disease in dogs",
        "Historical review, epidemiology and natural history of degenerative mitral valve disease",
        "An update on treatment and prognostic indicators in canine myxomatous mitral valve disease",
        "Aging and cardiac fibrosis",
        "Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease",
        "Fibrogenesis: Cellular and Colecular Basis",
        "Local expression of myocardial galectin-3 does not correlate with its serum levels in patients undergoing heart transplantation",
        "Plasma Biomarkers of Myocardial Fibrosis and Remodeling in Terminal Heart Failure Patients Supported by Mechanical Circulatory Support Devices",
        "Prognostic value of changes in galectin-3 levels over time in patients with heart failure data from CORONA and COACH",
        "Galectin-3: A new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure",
        "Associations between N-terminal procollagen type III, fibrosis and echocardiographic indices in dogs that died due to myxomatous mitral valve disease",
        "Serum PINP, PIIINP, galectin-3, and ST2 as surrogates of myocardial fibrosis and echocardiographic left venticular diastolic filling properties",
        "Galectin-3: An open-ended story",
        "Identification and characterization of endogenous galectins expressed in madin Darby canine kidney cells",
        "Galactoside Inhibitor of galectin-3 and Its Use for Treating Pulmonary Fibrosis"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University Graduate Commemorate the 72nd Anniversary of His Majesty King Bhumibol Adulyadej",
        "Ratchadaphiseksomphot Endowment Fund",
        "The 90th Anniversary of Chulalongkorn University Fund"
    ]
}